×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VYNE – vyne therapeutics inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VYNE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/23
10:08 am
vyne
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
Medium
Report
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
12/23
07:37 am
vyne
VYNE Therapeutics Reports Positive Top-line Phase 1a MAD Data for VYN202, its Novel BD2-Selective BET Inhibitor [Yahoo! Finance]
Medium
Report
VYNE Therapeutics Reports Positive Top-line Phase 1a MAD Data for VYN202, its Novel BD2-Selective BET Inhibitor [Yahoo! Finance]
12/23
07:30 am
vyne
VYNE Therapeutics Reports Positive Top-line Phase 1a MAD Data for VYN202, its Novel BD2-Selective BET Inhibitor
Medium
Report
VYNE Therapeutics Reports Positive Top-line Phase 1a MAD Data for VYN202, its Novel BD2-Selective BET Inhibitor
11/18
08:07 am
vyne
VYNE Therapeutics Inc. (NASDAQ: VYNE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $8.00 price target on the stock.
Low
Report
VYNE Therapeutics Inc. (NASDAQ: VYNE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $8.00 price target on the stock.
11/9
08:42 am
vyne
VYNE Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
VYNE Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
11/8
08:46 am
vyne
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
Low
Report
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
11/7
08:00 am
vyne
VYNE Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Medium
Report
VYNE Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
9/26
07:08 am
vyne
We Think VYNE Therapeutics (NASDAQ:VYNE) Needs To Drive Business Growth Carefully [Yahoo! Finance]
Low
Report
We Think VYNE Therapeutics (NASDAQ:VYNE) Needs To Drive Business Growth Carefully [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/23
07:43 am
vyne
Form 8-K VYNE Therapeutics Inc. For: Dec 23
Medium
Report
Form 8-K VYNE Therapeutics Inc. For: Dec 23
12/19
04:28 pm
vyne
Form S-8 VYNE Therapeutics Inc.
Medium
Report
Form S-8 VYNE Therapeutics Inc.
12/13
04:16 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: Sandoval Elisabeth
Neutral
Report
Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: Sandoval Elisabeth
12/13
04:16 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: LEPORE PATRICK G
Neutral
Report
Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: LEPORE PATRICK G
12/13
04:16 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: Bruno Anthony D
Neutral
Report
Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: Bruno Anthony D
12/13
04:16 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: BARBARI SHARON
Neutral
Report
Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: BARBARI SHARON
12/13
04:16 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: Borowski Christine
Neutral
Report
Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: Borowski Christine
12/13
04:16 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: Basta Steven L
Neutral
Report
Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: Basta Steven L
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: